Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury

Circulation. 2006 Aug 1;114(5):430-7. doi: 10.1161/CIRCULATIONAHA.105.602714. Epub 2006 Jul 24.

Abstract

Background: Studies in humans and animal models suggest that interleukin-18 (IL-18) plays a crucial role in vascular pathologies. IL-18 is a predictor of cardiovascular death in angina and is involved in atherotic plaque destabilization. Higher IL-18 plasma levels also are associated with restenosis after coronary artery angioplasty performed in patients with acute myocardial infarction. We investigated the effective role of IL-18 in neointimal formation in a balloon-induced rat model of vascular injury.

Methods and results: Endothelial denudation of the left carotid artery was performed by use of a balloon embolectomy catheter. Increased expression of IL-18 and IL-18Ralpha/beta mRNA was detectable in carotid arteries from days 2 to 14 after angioplasty. The active form of IL-18 was highly expressed in injured arteries. Strong immunoreactivity for IL-18 was detected in the medial smooth muscle cells at days 2 and 7 after balloon injury and in proliferating/migrating smooth muscle cells in neointima at day 14. Moreover, serum concentrations of IL-18 were significantly higher among rats subjected to vascular injury. Treatment with neutralizing rabbit anti-rat IL-18 immunoglobulin G significantly reduced neointimal formation (by 27%; P < 0.01), reduced the number of proliferating cells, and inhibited interferon-gamma, IL-6, and IL-8 mRNA expression and nuclear factor-kappaB activation in injured arteries. In addition, in vitro data show that IL-18 affects smooth muscle cell proliferation.

Conclusions: These results identify a critical role for IL-18 in neointimal formation in a rat model of vascular injury and suggest a potential role for IL-18 neutralization in the reduction of neointimal development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / analysis
  • Animals
  • Balloon Occlusion / adverse effects
  • Cardiovascular Diseases / physiopathology*
  • Carotid Arteries / chemistry
  • Carotid Arteries / pathology
  • Carotid Arteries / physiopathology
  • Carotid Artery Injuries / etiology*
  • Carotid Artery Injuries / pathology
  • Carotid Artery Injuries / physiopathology*
  • Cell Movement / drug effects
  • Cell Movement / physiology
  • Cell Proliferation / drug effects
  • Disease Models, Animal
  • Endothelium, Vascular / injuries
  • Endothelium, Vascular / pathology
  • Endothelium, Vascular / physiopathology
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology
  • Immunoglobulin G / pharmacology
  • Interferon-gamma / analysis
  • Interferon-gamma / genetics
  • Interferon-gamma / physiology
  • Interleukin-18 / analysis
  • Interleukin-18 / blood
  • Interleukin-18 / genetics
  • Interleukin-18 / physiology*
  • Interleukin-6 / analysis
  • Interleukin-6 / genetics
  • Interleukin-6 / physiology
  • Interleukin-8 / analysis
  • Interleukin-8 / genetics
  • Interleukin-8 / physiology
  • Male
  • Muscle, Smooth, Vascular / pathology
  • Muscle, Smooth, Vascular / physiopathology
  • NF-kappa B / analysis
  • NF-kappa B / physiology
  • RNA, Messenger / analysis
  • RNA, Messenger / genetics
  • Rats
  • Rats, Wistar
  • Time Factors
  • Tunica Intima / pathology
  • Tunica Intima / physiopathology*

Substances

  • Actins
  • Immunoglobulin G
  • Interleukin-18
  • Interleukin-6
  • Interleukin-8
  • NF-kappa B
  • RNA, Messenger
  • smooth muscle actin, rat
  • Interferon-gamma